Loading…
Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland
Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead...
Saved in:
Published in: | BMC pediatrics 2014-05, Vol.14 (1), p.125-125, Article 125 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73 |
---|---|
cites | cdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73 |
container_end_page | 125 |
container_issue | 1 |
container_start_page | 125 |
container_title | BMC pediatrics |
container_volume | 14 |
creator | Pelc, Raphaëlle Redant, Sébastien Julliand, Sébastien Llor, Juan Lorrot, Mathie Oostenbrink, Rianne Gajdos, Vincent Angoulvant, François |
description | Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland.
An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test.
We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics.
We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group. |
doi_str_mv | 10.1186/1471-2431-14-125 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4045874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A539587046</galeid><sourcerecordid>A539587046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</originalsourceid><addsrcrecordid>eNptkt2L1DAUxYso7u7ou08SEGQfpmvSJP3wQRgX1xUGFVyfQ5rctlnaZkzSkfXBv92UWceZRQrt5eZ3TpLbkyQvCL4gpMzfEFaQNGOUpISlJOOPktN96_FBfZKceX-LMSlKlj9NTjJWxoJUp8nvr6CNDM4o1EofnIUxgDPBeGRGFDpAMIBrYVR3SMNGujBE4i3aOKmCUXF5K_tJBmPHWfAe-tZMwxJdOTkqWKKb6PAZoo_r5ag9ii_07acJv3aNZ8mTRvYent9_F8n3qw83l9fp-svHT5erdao4r0IKGGjV6JrkuC54ltWM6FrqhuZZpXkNjZJZWeqacVo3XKucaKrrinDZSNzogi6SdzvfzVQPoFW8g5O92DgzSHcnrDTieGU0nWjtVjDMeFmwaLDcGXQPZNertTCjBzcInGFeVlm5JRE_v9_P2R8T-CAG4xX08c5gJy8Ip1nFKsZm51cP0Fs7uTFOY6YKwnJKyT-qlT3EDRsbj6lmU7HitIpnxBFcJBf_oeKjYTDKjtCY2D8SvD4QdCD70HnbT_P_9Mcg3oHKWe8dNPshECzmLIo5bGIOW6xEzGKUvDyc-V7wN3z0D9xc2j4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1537146331</pqid></control><display><type>article</type><title>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Pelc, Raphaëlle ; Redant, Sébastien ; Julliand, Sébastien ; Llor, Juan ; Lorrot, Mathie ; Oostenbrink, Rianne ; Gajdos, Vincent ; Angoulvant, François</creator><creatorcontrib>Pelc, Raphaëlle ; Redant, Sébastien ; Julliand, Sébastien ; Llor, Juan ; Lorrot, Mathie ; Oostenbrink, Rianne ; Gajdos, Vincent ; Angoulvant, François</creatorcontrib><description>Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland.
An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test.
We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics.
We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.</description><identifier>ISSN: 1471-2431</identifier><identifier>EISSN: 1471-2431</identifier><identifier>DOI: 10.1186/1471-2431-14-125</identifier><identifier>PMID: 24884619</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abdomen - diagnostic imaging ; Age ; Analysis ; Antidiarrheals - therapeutic use ; Antiemetics - therapeutic use ; Belgium ; Blood Cell Count - utilization ; Blood Gas Analysis - utilization ; C-Reactive Protein - analysis ; Children & youth ; Cross-Sectional Studies ; Data analysis ; Dehydration - etiology ; Dehydration - therapy ; Electrolytes ; Electrolytes - blood ; Emergency Service, Hospital ; Endorsements ; Epidemiology ; Feces - virology ; Fluid Therapy - methods ; France ; Gastroenteritis - complications ; Gastroenteritis - therapy ; Gastroenterology ; Hepatology ; Hospitalization ; Human health and pathology ; Humans ; Life Sciences ; Netherlands ; Nutrition ; Ondansetron - therapeutic use ; Pediatrics ; Physicians ; Practice Patterns, Physicians' - statistics & numerical data ; Probiotics - therapeutic use ; Studies ; Surveys and Questionnaires ; Switzerland ; Teaching hospitals ; Thiorphan - analogs & derivatives ; Thiorphan - therapeutic use ; Ultrasonography ; Urinalysis - utilization</subject><ispartof>BMC pediatrics, 2014-05, Vol.14 (1), p.125-125, Article 125</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Pelc et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2014 Pelc et al.; licensee BioMed Central Ltd. 2014 Pelc et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</citedby><cites>FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045874/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1537146331?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24884619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-02058928$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pelc, Raphaëlle</creatorcontrib><creatorcontrib>Redant, Sébastien</creatorcontrib><creatorcontrib>Julliand, Sébastien</creatorcontrib><creatorcontrib>Llor, Juan</creatorcontrib><creatorcontrib>Lorrot, Mathie</creatorcontrib><creatorcontrib>Oostenbrink, Rianne</creatorcontrib><creatorcontrib>Gajdos, Vincent</creatorcontrib><creatorcontrib>Angoulvant, François</creatorcontrib><title>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</title><title>BMC pediatrics</title><addtitle>BMC Pediatr</addtitle><description>Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland.
An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test.
We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics.
We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.</description><subject>Abdomen - diagnostic imaging</subject><subject>Age</subject><subject>Analysis</subject><subject>Antidiarrheals - therapeutic use</subject><subject>Antiemetics - therapeutic use</subject><subject>Belgium</subject><subject>Blood Cell Count - utilization</subject><subject>Blood Gas Analysis - utilization</subject><subject>C-Reactive Protein - analysis</subject><subject>Children & youth</subject><subject>Cross-Sectional Studies</subject><subject>Data analysis</subject><subject>Dehydration - etiology</subject><subject>Dehydration - therapy</subject><subject>Electrolytes</subject><subject>Electrolytes - blood</subject><subject>Emergency Service, Hospital</subject><subject>Endorsements</subject><subject>Epidemiology</subject><subject>Feces - virology</subject><subject>Fluid Therapy - methods</subject><subject>France</subject><subject>Gastroenteritis - complications</subject><subject>Gastroenteritis - therapy</subject><subject>Gastroenterology</subject><subject>Hepatology</subject><subject>Hospitalization</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Netherlands</subject><subject>Nutrition</subject><subject>Ondansetron - therapeutic use</subject><subject>Pediatrics</subject><subject>Physicians</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Probiotics - therapeutic use</subject><subject>Studies</subject><subject>Surveys and Questionnaires</subject><subject>Switzerland</subject><subject>Teaching hospitals</subject><subject>Thiorphan - analogs & derivatives</subject><subject>Thiorphan - therapeutic use</subject><subject>Ultrasonography</subject><subject>Urinalysis - utilization</subject><issn>1471-2431</issn><issn>1471-2431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkt2L1DAUxYso7u7ou08SEGQfpmvSJP3wQRgX1xUGFVyfQ5rctlnaZkzSkfXBv92UWceZRQrt5eZ3TpLbkyQvCL4gpMzfEFaQNGOUpISlJOOPktN96_FBfZKceX-LMSlKlj9NTjJWxoJUp8nvr6CNDM4o1EofnIUxgDPBeGRGFDpAMIBrYVR3SMNGujBE4i3aOKmCUXF5K_tJBmPHWfAe-tZMwxJdOTkqWKKb6PAZoo_r5ag9ii_07acJv3aNZ8mTRvYent9_F8n3qw83l9fp-svHT5erdao4r0IKGGjV6JrkuC54ltWM6FrqhuZZpXkNjZJZWeqacVo3XKucaKrrinDZSNzogi6SdzvfzVQPoFW8g5O92DgzSHcnrDTieGU0nWjtVjDMeFmwaLDcGXQPZNertTCjBzcInGFeVlm5JRE_v9_P2R8T-CAG4xX08c5gJy8Ip1nFKsZm51cP0Fs7uTFOY6YKwnJKyT-qlT3EDRsbj6lmU7HitIpnxBFcJBf_oeKjYTDKjtCY2D8SvD4QdCD70HnbT_P_9Mcg3oHKWe8dNPshECzmLIo5bGIOW6xEzGKUvDyc-V7wN3z0D9xc2j4</recordid><startdate>20140516</startdate><enddate>20140516</enddate><creator>Pelc, Raphaëlle</creator><creator>Redant, Sébastien</creator><creator>Julliand, Sébastien</creator><creator>Llor, Juan</creator><creator>Lorrot, Mathie</creator><creator>Oostenbrink, Rianne</creator><creator>Gajdos, Vincent</creator><creator>Angoulvant, François</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope></search><sort><creationdate>20140516</creationdate><title>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</title><author>Pelc, Raphaëlle ; Redant, Sébastien ; Julliand, Sébastien ; Llor, Juan ; Lorrot, Mathie ; Oostenbrink, Rianne ; Gajdos, Vincent ; Angoulvant, François</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abdomen - diagnostic imaging</topic><topic>Age</topic><topic>Analysis</topic><topic>Antidiarrheals - therapeutic use</topic><topic>Antiemetics - therapeutic use</topic><topic>Belgium</topic><topic>Blood Cell Count - utilization</topic><topic>Blood Gas Analysis - utilization</topic><topic>C-Reactive Protein - analysis</topic><topic>Children & youth</topic><topic>Cross-Sectional Studies</topic><topic>Data analysis</topic><topic>Dehydration - etiology</topic><topic>Dehydration - therapy</topic><topic>Electrolytes</topic><topic>Electrolytes - blood</topic><topic>Emergency Service, Hospital</topic><topic>Endorsements</topic><topic>Epidemiology</topic><topic>Feces - virology</topic><topic>Fluid Therapy - methods</topic><topic>France</topic><topic>Gastroenteritis - complications</topic><topic>Gastroenteritis - therapy</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Hospitalization</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Netherlands</topic><topic>Nutrition</topic><topic>Ondansetron - therapeutic use</topic><topic>Pediatrics</topic><topic>Physicians</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Probiotics - therapeutic use</topic><topic>Studies</topic><topic>Surveys and Questionnaires</topic><topic>Switzerland</topic><topic>Teaching hospitals</topic><topic>Thiorphan - analogs & derivatives</topic><topic>Thiorphan - therapeutic use</topic><topic>Ultrasonography</topic><topic>Urinalysis - utilization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pelc, Raphaëlle</creatorcontrib><creatorcontrib>Redant, Sébastien</creatorcontrib><creatorcontrib>Julliand, Sébastien</creatorcontrib><creatorcontrib>Llor, Juan</creatorcontrib><creatorcontrib>Lorrot, Mathie</creatorcontrib><creatorcontrib>Oostenbrink, Rianne</creatorcontrib><creatorcontrib>Gajdos, Vincent</creatorcontrib><creatorcontrib>Angoulvant, François</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pelc, Raphaëlle</au><au>Redant, Sébastien</au><au>Julliand, Sébastien</au><au>Llor, Juan</au><au>Lorrot, Mathie</au><au>Oostenbrink, Rianne</au><au>Gajdos, Vincent</au><au>Angoulvant, François</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</atitle><jtitle>BMC pediatrics</jtitle><addtitle>BMC Pediatr</addtitle><date>2014-05-16</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>125</spage><epage>125</epage><pages>125-125</pages><artnum>125</artnum><issn>1471-2431</issn><eissn>1471-2431</eissn><abstract>Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland.
An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test.
We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics.
We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24884619</pmid><doi>10.1186/1471-2431-14-125</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2431 |
ispartof | BMC pediatrics, 2014-05, Vol.14 (1), p.125-125, Article 125 |
issn | 1471-2431 1471-2431 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4045874 |
source | Publicly Available Content Database; PubMed Central |
subjects | Abdomen - diagnostic imaging Age Analysis Antidiarrheals - therapeutic use Antiemetics - therapeutic use Belgium Blood Cell Count - utilization Blood Gas Analysis - utilization C-Reactive Protein - analysis Children & youth Cross-Sectional Studies Data analysis Dehydration - etiology Dehydration - therapy Electrolytes Electrolytes - blood Emergency Service, Hospital Endorsements Epidemiology Feces - virology Fluid Therapy - methods France Gastroenteritis - complications Gastroenteritis - therapy Gastroenterology Hepatology Hospitalization Human health and pathology Humans Life Sciences Netherlands Nutrition Ondansetron - therapeutic use Pediatrics Physicians Practice Patterns, Physicians' - statistics & numerical data Probiotics - therapeutic use Studies Surveys and Questionnaires Switzerland Teaching hospitals Thiorphan - analogs & derivatives Thiorphan - therapeutic use Ultrasonography Urinalysis - utilization |
title | Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A21%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pediatric%20gastroenteritis%20in%20the%20emergency%20department:%20practice%20evaluation%20in%20Belgium,%20France,%20The%20Netherlands%20and%20Switzerland&rft.jtitle=BMC%20pediatrics&rft.au=Pelc,%20Rapha%C3%ABlle&rft.date=2014-05-16&rft.volume=14&rft.issue=1&rft.spage=125&rft.epage=125&rft.pages=125-125&rft.artnum=125&rft.issn=1471-2431&rft.eissn=1471-2431&rft_id=info:doi/10.1186/1471-2431-14-125&rft_dat=%3Cgale_pubme%3EA539587046%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1537146331&rft_id=info:pmid/24884619&rft_galeid=A539587046&rfr_iscdi=true |